ArticleWorld journal of urology2021
The state of TURP through a historical lens.
Article in World journal of urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Endoscopic enucleation of the prostate versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review and meta-analysis.Prostate cancer and prostatic diseases · 2025Pooled it
- Transurethral resection of the prostate across continents: a meta-analysis evaluating quality of gold standard in the twenty-first century.World journal of urology · 2025Pooled it
- Evaluating transurethral resection of the prostate over twenty years: a systematic review and meta-analysis of randomized clinical trials.World journal of urology · 2024Pooled it
- Suprapubic transvesical adenoma resection versus robot-assisted simple prostatectomy for prostates ≥ 80 mL: an exploratory early-outcome comparison.World journal of urology · 2026Article
- Holmium laser enucleation of the prostate versus transurethral resection of the prostate for benign prostatic hyperplasia: evidence from a Korean retrospective analysis using the Common Data Model.Prostate international · 2026Article
- Multiorgan involvement and residual effects in transurethral resection of prostate syndrome: A case report and literature review.Urology case reports · 2026Article
- The dark side of transurethral access for LUTS/BPH surgery: a narrative review.Asian journal of andrology · 2026Review
- Article
- Evaluating the utility of the HAS-BLED bleeding-estimator tool for transurethral resection of prostate.BJUI compass · 2025Article
- A comparison of TURP, HoLEP, and RFA for nonneurogenic LUTS in men.Turkish journal of medical sciences · 2025Article
- Comparison of perioperative bleeding risk between direct oral anticoagulants in transurethral resection of prostate.BJU international · 2024Article
- Current era HOLEP with MOSES 2.0 technology compared to the gold standard TURP.World journal of urology · 2024Article
- MRI-guided transrectal prostate laser ablation for benign prostatic hypertrophy: a retrospective cohort study.La Radiologia medica · 2024Article
- Article
- Minimally invasive techniques in quest of Holy Grail of surgical management of enlarged prostates: a narrative review.World journal of urology · 2024Review
- Comparative RNA-sequencing analysis of the prostate in a mouse model of benign prostatic hyperplasia with bladder outlet obstruction.Molecular and cellular biochemistry · 2023Article
- TURPxit or not: contemporary management options for benign prostatic obstruction.World journal of urology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 1926 Maximilian Stern introduced a new instrument to treat obstructions at the vesical orifice and baptized it resectoscope. With reference to astonishing historical statements about the new instrument and surgical technique made by the pioneers and their critics we will value why transurethral resection of the prostate (TURP) remains the gold standard for most men suffering from lower urinary tract symptoms (LUTS) due to benign prostatic enlargement. TURP is currently challenged by recently introduced new instruments and techniques claiming advantages over TURP. However, TURP offers an excellent balance between high efficacy in symptom relieve and low morbidity along with low costs and favorable long term outcome compared to other treatment options. We will outline these arguments demonstrating that even after a century has elapsed, since its introduction into the urologists armamentarium, TURP continues to stand the passage of time.
Indexed as
Identifiers
33772604What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.